Bigul

ANUH PHARMA LTD. - 506260 - Board Meeting Intimation for Prior Intimation Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 ,inter alia, to consider and approve 1) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2023; and 2) To consider any other matter with the permission of the Chairman.
03-08-2023
Bigul

ANUH PHARMA LTD. - 506260 - Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report.
25-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - Corporate Action - Fixes Record Date For Dividend And Annual General Meeting

Fixes Record Date For Dividend and Annual General Meeting.
25-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 (LODR)-Updates

Announcement under Regulation 30 (LODR)-Updates
24-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - General-Updates

General-Updates
23-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - Announcement Under Regulation 30 (LODR)-Update

Disclosure of Event/Information-Approval from EDQM for CEP of Azithromycin API.
13-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate Under Regulation 74 (5) for the Quarter Ended 30th June, 2023
10-07-2023
Bigul

ANUH PHARMA LTD. - 506260 - Closure of Trading Window

Intimation of Trading Window Closure as per SEBI (Prohibition of Insider Trading) Regulations, 2015.
30-06-2023
Bigul

ANUH PHARMA LTD. - 506260 - Announcement Umder Reg 30 Of LODR

Reply to your email dated 16th June, 2023 on clarification on Price Movement`
23-06-2023
Next Page
Close

Let's Open Free Demat Account